However, it is possible that IFITM1 could serve as a negative regulator as it has previously been found to be a negative regulator in certain contexts, with suppression of IFITM1 inhibiting proliferation in glioma cells (36). This evidence concerns the gene IFITM1 and central nervous system cancer.